Yongin, South Korea

Myoung Sil Ko

This inventor holds 1 USPTO granted patent. Top assignees: Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Myoung Sil Ko. Retrieved from https://idiyas.com/inventor/myoung-sil-ko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Myoung Sil Ko: Innovator in Protein Kinase Inhibition

Introduction

Myoung Sil Ko is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target protein kinases.

Latest Patents

Myoung Sil Ko holds a patent for "Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase." This invention relates to a novel bicyclic heteroaryl derivative, along with its pharmaceutically acceptable salts, hydrates, and solvates. The compound demonstrates improved inhibitory activity for protein kinases and is part of a pharmaceutical composition aimed at preventing or treating abnormal cell growth disorders.

Career Highlights

Throughout his career, Myoung Sil Ko has worked with prominent companies in the pharmaceutical industry, including Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His work has focused on innovative solutions to complex medical challenges, particularly in the realm of cancer treatment.

Collaborations

Myoung Sil Ko has collaborated with esteemed colleagues such as Seung Hyun Jung and Young Hee Jung. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Myoung Sil Ko's contributions to the field of protein kinase inhibition highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…